CD19-CAR_Lenti T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19-CAR_Lenti T Cells, covering 2025-12-02 to 2025-12-02. Get the full timeline:
Most recent: Clinical Trial Update: CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML [Phase 1, Phase 2]